Similar articles

• [Beta-blockers and chronic obstructive pulmonary disease].

  Sova M, Kamasová M, Václavík J, Sovová E, Hajdová L, Kolek V. Sova M, et al. Vnitr Lek. 2016 Apr;62(4):305-7. Vnitr Lek. 2016. PMID: 27250608 Czech.
• A curious case of beta-blockers in chronic obstructive pulmonary disease.

  Sin DD, Man SF. Sin DD, et al. Arch Intern Med. 2010 May 24;170(10):849-50. doi: 10.1001/archinternmed.2010.97. Arch Intern Med. 2010. PMID: 20498410 No abstract available.
• [Beta blockers and cardiovascular risk in chronic obstructive pulmonary disease].

  Machado-Alba JE, Medina-Morales DA, Bañol-Giraldo AM, Machado-Duque ME. Machado-Alba JE, et al. Rev Med Chil. 2014 Jun;142(6):807-8. doi: 10.4067/S0034-98872014000600019. Rev Med Chil. 2014. PMID: 25327330 Spanish. No abstract available.
• Use of beta-blockers in patients with COPD.

  Andrus MR, Holloway KP, Clark DB. Andrus MR, et al. Ann Pharmacother. 2004 Jan;38(1):142-5. doi: 10.1345/aph.1D113. Ann Pharmacother. 2004. PMID: 14742808 Review.
• [Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].

  Bułdak Ł, Duława A, Krysiak R, Okopień B. Bułdak Ł, et al. Pol Merkur Lekarski. 2008 Feb;24(140):121-4. Pol Merkur Lekarski. 2008. PMID: 18637263 Review. Polish.